$ERAS leads the live board in Mixed Basket with a Factor Residual Spike

🇺🇸 A rotation is underway within the equities space, with $ERAS (Erasca, Inc.) emerging as the active setup in the mixed basket. The unusual relative-strength move in ERAS, a clinical-stage biotech focused on RAS/MAPK pathway-driven cancers, signals a potential shift amid broad market uncertainty. While the market remains stable with 56% breadth and inflows, the move in ERAS suggests some underlying sector-specific interest, especially since most movers are in Healthcare, a sector aligned with biotech's growth prospects. The proof lies in the recent inflow and the confirmed residual spike, which indicates a fresh divergence from the broader market’s steadiness. FICO, the leader in this rotation, is setting the tone, with ERAS following through as a key name to watch. The pattern points to an evolving mixed theme centered around Healthcare, but the confirmation is still early. The next step is to monitor for a second wave of linked names, especially in Healthcare Plans and biotech, to confirm whether this rotation gains traction or remains a fleeting move.